WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

WMT

125.11

-0.71%↓

COST

996.16

-0.57%↓

PG

151.49

-0.36%↓

KO

77.6

-0.26%↓

PM

172.78

-1.1%↓

Search

USANA Health Sciences Inc

Fechado

17.63 0.46

Visão Geral

Variação de preço das ações

24h

Atual

Mín

17.4

Máximo

17.92

Indicadores-chave

By Trading Economics

Rendimento

5.1M

-1.6M

Vendas

13M

226M

P/E

Médio do Setor

30.241

28.214

EPS

-0.15

Margem de lucro

-0.705

Funcionários

1,700

EBITDA

16M

28M

Dividendos

By Dow Jones

Próximos Ganhos

21 de abr. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-61M

321M

Abertura anterior

17.17

Fecho anterior

17.63

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

USANA Health Sciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

17 de mar. de 2026, 22:42 UTC

Ganhos

Prudential PLC 2025 Adjusted Operating Profit Rises

17 de mar. de 2026, 21:40 UTC

Ganhos

Alimentation Couche-Tard Records Higher Profit, Revenue in 3Q

17 de mar. de 2026, 23:56 UTC

Conversa de Mercado

BHP's Next CEO Likely to Build On Existing Strategic Direction -- Market Talk

17 de mar. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise After Recent Selloffs -- Market Talk

17 de mar. de 2026, 23:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de mar. de 2026, 23:42 UTC

Conversa de Mercado

RBA's Return to Policy Tightening Will Work -- Market Talk

17 de mar. de 2026, 23:38 UTC

Conversa de Mercado

Gold Edges Lower on Possible Position Adjustments Before FOMC Decision -- Market Talk

17 de mar. de 2026, 23:24 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

17 de mar. de 2026, 23:24 UTC

Conversa de Mercado

New Woodside CEO Seen as Low-Risk Appointment -- Market Talk

17 de mar. de 2026, 22:22 UTC

Conversa de Mercado

BHP Hands Reins to Growth-Focused Executive -- Market Talk

17 de mar. de 2026, 22:20 UTC

Ganhos

Prudential PLC 2025 New Business Profit $2.78B Vs. $2.46B >2378.HK

17 de mar. de 2026, 22:20 UTC

Ganhos

Prudential PLC 2025 Adj Operating Profit $3.31B Vs. $3.13B >2378.HK

17 de mar. de 2026, 22:07 UTC

Ganhos

Nvidia Says It Is Restarting Production of AI Chips for Sale in China -- WSJ

17 de mar. de 2026, 22:05 UTC

Ganhos

ZTO Express (Cayman): Frank Zhen Wei to Resign From Board

17 de mar. de 2026, 22:04 UTC

Ganhos

ZTO Express (Cayman): Board Approves Repurchase of Up to $1.5B of Shares Over Next 24 Months >ZTO

17 de mar. de 2026, 22:03 UTC

Ganhos

ZTO Express (Cayman) Raises Semiannual Dividend to 39c Vs. 30c >ZTO

17 de mar. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 4Q Adj EPS 47c >ZTO

17 de mar. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 4Q Rev $2.08B >ZTO

17 de mar. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 4Q EPS 47c >ZTO

17 de mar. de 2026, 21:26 UTC

Ganhos

Oklo Stock Wavers After Earnings, but the Nuclear Start-Up Has Good News -- Barrons.com

17 de mar. de 2026, 21:09 UTC

Ganhos

Couche-Tard: 12 Company-Operated Stores Acquired During 3Q

17 de mar. de 2026, 21:08 UTC

Ganhos

Couche-Tard 3Q Consolidated Same-Store Merchandise Revenue Up 2% >ATD.T

17 de mar. de 2026, 21:08 UTC

Ganhos

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 de mar. de 2026, 21:07 UTC

Ganhos

Couche-Tard 3Q EPS 82c >ATD.T

17 de mar. de 2026, 21:06 UTC

Ganhos

Couche-Tard 3Q Rev $21.8B >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q Adj EPS 81c >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q Rev $21.8B >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q EPS 82c >ATD.T

17 de mar. de 2026, 21:05 UTC

Ganhos

Couche-Tard 3Q Net $757.2M >ATD.T

17 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Energy & Utilities Roundup: Market Talk

Comparação entre Pares

Variação de preço

USANA Health Sciences Inc Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Pontuação Técnica

By Trading Central

28.405 / 29.84Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat